Fundz

Nuvation Bio Inc. reported raising $275 Million in an initial SEC Form D filing, from an offering of $275 Million

PUBLIC · NUVBOct 20, 2020

Amount Raised

$275 Million

$275 Million sold, per SEC Form D (first sale Oct 20, 2020)

Round Type

Venture

New YorkBiotechnologyHealthcareHealth CareTherapeuticsBiopharma

Quick answer

Nuvation Bio raised $275 Million in a funding round, dated October 20, 2020. Nuvation Bio is based in New York, New York, United States.

How much did Nuvation Bio raise?
Nuvation Bio raised $275 Million in a funding round on October 20, 2020.
What does Nuvation Bio do?
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates.
Where is Nuvation Bio based and how big is it?
Nuvation Bio is based in New York, New York, United States.
Who are the decision-makers at Nuvation Bio?
Fundz holds 1 contact at Nuvation Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Nuvation Bio that raised within 45 days of this round, from Fundz verified event records.

Who to call at Nuvation Bio, and when

A new round usually means Nuvation Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nuvation Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nuvation Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nuvation Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nuvation Bio

Location

New York, New York, United States

About

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco. For more information, please visit www.nuvationbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nuvation Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts8 people are listed at Nuvation Bio. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Nuvation Bio's next move

See what Strategic adds

Nuvation Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.